Advanced in Immune Defect due to Absence of Thymus

Claudio Pignata

Naples, IT 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Immune Defect due to Absence of Thymus
Naples, IT 
OverviewLocationsClinical Research

Overview

Claudio Pignata practices in Naples, Italy. Mr. Pignata is rated as an Advanced expert by MediFind in the treatment of Immune Defect due to Absence of Thymus. His top areas of expertise are Pignata Guarino Syndrome, Ataxia-Telangiectasia, Primary Immunodeficiency (PID), Splenectomy, and Bone Marrow Transplant.

His clinical research consists of co-authoring 161 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 14 articles in the study of Immune Defect due to Absence of Thymus.

Gender
Male

Locations

Naples, Italy
Other Locations
Italy
Corso, 80138, Italy
Padova, Italy
Turin, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety, and Pharmacokinetics of Kedrion Intravenous Human Normal Immunoglobulin (IVIg) 10% in Pediatric Patients Affected by Primary Immunodeficiency Disease (PID)
A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety, and Pharmacokinetics of Kedrion Intravenous Human Normal Immunoglobulin (IVIg) 10% in Pediatric Patients Affected by Primary Immunodeficiency Disease (PID)
Enrollment Status: Recruiting
Publish Date: August 21, 2025
Intervention Type: Biological
Study Phase: Phase 3

161 Total Publications

Case Report: Life-threatening overlap of hemophagocytic syndrome and atypical hemolytic uremic syndrome in a patient with autoimmune polyglandular syndrome type 1 successfully treated with targeted immunotherapy.
Case Report: Life-threatening overlap of hemophagocytic syndrome and atypical hemolytic uremic syndrome in a patient with autoimmune polyglandular syndrome type 1 successfully treated with targeted immunotherapy.
Journal: Frontiers in immunology
Published: July 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pignata's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 13 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile